Hemab Therapeutics Holdings, Inc.

COAG - Company ID 0002114044

Market cap$1.74 B

Rank#2257

Filings38

Hemab Therapeutics Holdings, Inc. has filed 38 public company documents between 2026 and 2026. The most frequent type is new insider ownership (11 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchCOAG overview$1.74 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2257See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut COAG beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow COAG via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

MRNAModerna, Inc.

BIIBBiogen Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
4	Insider trade	1mo ago2026-05-21	2026-05-19	View filing
10-Q	Quarterly report	1mo ago2026-05-21	2026-03-31	View filing
8-K	Major company event	1mo ago2026-05-21	2026-05-21	View filing
4	Insider trade	1mo ago2026-05-14	2026-05-12	View filing
3	New insider ownership	1mo ago2026-05-14	2026-05-04	View filing
SCHEDULE 13G	SCHEDULE 13G	1mo ago2026-05-11	-	View filing
4	Insider trade	1mo ago2026-05-11	2026-05-07	View filing
SCHEDULE 13D	SCHEDULE 13D	1mo ago2026-05-11	-	View filing
8-K	Major company event	1mo ago2026-05-11	2026-05-08	View filing
SCHEDULE 13G	SCHEDULE 13G	2mo ago2026-05-08	-	View filing
4	Insider trade	2mo ago2026-05-06	2026-05-04	View filing
4	Insider trade	2mo ago2026-05-06	2026-05-04	View filing
4	Insider trade	2mo ago2026-05-04	2026-01-29	View filing
4	Insider trade	2mo ago2026-05-04	2026-01-29	View filing
4	Insider trade	2mo ago2026-05-04	2026-01-29	View filing
8-K	Major company event	2mo ago2026-05-04	2026-05-04	View filing
S-8	Employee stock plan	2mo ago2026-05-04	-	View filing
424B4	424B4	2mo ago2026-05-01	-	View filing
EFFECT	EFFECT	2mo ago2026-04-30	-	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
CERT	Exchange certification	2mo ago2026-04-30	-	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
3	New insider ownership	2mo ago2026-04-30	2026-04-30	View filing
S-1MEF	S-1MEF	2mo ago2026-04-30	-	View filing
S-1/A	S-1/A	2mo ago2026-04-30	-	View filing
S-1/A	S-1/A	2mo ago2026-04-28	-	View filing
8-A12B	8-A12B	2mo ago2026-04-27	-	View filing
S-1/A	S-1/A	2mo ago2026-04-27	-	View filing
S-1	IPO registration	3mo ago2026-04-10	-	View filing
DRS/A	DRS/A	3mo ago2026-04-02	-	View filing
DRS	DRS	4mo ago2026-02-27	-	View filing

Hemab Therapeutics Holdings, Inc.

Similar companies to research next

Year